jiuzhou-drugstore.com (CJJD): Forward Price-to-Revenue Multiple

jiuzhou-drugstore.com (CJJD) - corporate logo

Is it worth investing in China Jo-Jo Drugstores (CJJD), given the strict government control over drug circulation and licensing requirements? The forward P/S valuation provides the answer, where the 0.10 metric determines this level. China Jo-Jo Drugstores (CJJD) is scaling its network through digital partnerships with clinics and marketplaces; however, rigid price regulations and the expansion of Chinese online platforms are gradually eroding its market resilience and margins.

CJJD China Jo-Jo Drugstores Inc.: Price to Expected Revenue Ratio in the range 07/04/2022 - 03/04/2025

Analytical breakdowns and data insights for company China Jo-Jo Drugstores Inc. (CJJD)

General company analysis:CJJD (Jiuzhou 360)
Manufactured products of China Jo-Jo Drugstores, Inc.

The stable operation of distribution centers and the modernization of logistics at China Jo-Jo Drugstores (CJJD) create a foundation for revenue growth, as reflected in the projected market cap-to-revenue ratio on the GURU.Markets platform. By dividing the company's market value by projected sales, this indicator determines the degree of asset undervaluation and assesses the efficiency of business scaling relative to its current stock price.